[REGN] QoQ Quarter Result on 31-Dec-2012 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
15-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- 145.68%
YoY- 980.20%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 597,027 457,642 439,664 414,602 427,687 304,399 231,789 87.79%
PBT 225,684 147,692 141,831 134,559 191,468 76,743 11,651 619.96%
Tax 84,378 60,316 42,957 -335,848 -517 -501 -610 -
NP 141,306 87,376 98,874 470,407 191,468 76,743 11,651 427.07%
Tax Rate -37.39% -40.84% -30.29% 249.59% 0.27% 0.65% 5.24% -
Total Cost 455,721 370,266 340,790 -55,805 236,219 227,656 220,138 62.35%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin 23.67 19.09 22.49 113.46 44.77 25.21 5.03 180.55%
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
EPS 1.44 0.89 1.02 4.92 2.02 0.81 0.12 423.35%
EPS Diluted 1.25 0.79 0.90 4.26 1.72 0.70 0.11 404.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.